Liver transplantation with donation after medical assistance in dying: Case series and systematic review of the literature : Liver Transplantation

Secondary Logo

Journal Logo

Original Articles: Peritransplant and Posttransplant Management and Outcomes

Liver transplantation with donation after medical assistance in dying: Case series and systematic review of the literature

Glinka, Juan1; Sachar, Yashasavi2; Tang, Ephraim1; Brahmania, Mayur2,3; Hwang, Jaehyun1; Waugh, Evelyn1; Schmerk, Crystal2; Iansavitchene, Alla4; Quan, Douglas1; Skaro, Anton1

Author Information
Liver Transplantation 29(6):p 618-625, June 2023. | DOI: 10.1097/LVT.0000000000000100

Abstract

Medical assistance in dying (MAiD) has been a legally approved practice in Canada since 2016. Only recently have patients undergoing MAiD also been considered as donors for liver transplantation (LT). This study aimed to evaluate a case series of LT outcomes for recipients with MAiD donors and was paired with a systematic literature review of studies assessing the efficacy of MAiD-associated liver donation. A retrospective chart review of patients registered within the LT Registry at London Health Sciences Centre (LHSC) in London, Ontario, Canada, that had received MAiD donor LT was conducted to develop a case series. Descriptive statistics were produced based on available patient outcomes information. The systematic review included euthanasia due to MAiD being a term exclusive to Canada. Case series had a 100% 1-year graft survival rate, with 50% of patients experiencing early allograft dysfunction but having no significant clinical outcome. A single case of postoperative biliary complication was reported. Median warm ischemic time ranged from 7.8–13 minutes among case series and literature reviews. Utilization of donation after circulatory death allografts procured after MAiD appears to be promising. Mechanisms associated with potential impact in postoperative outcomes include relatively lower warm ischemic time relative to donation after circulatory death Maastricht III graft recipients.

Copyright © 2023 American Association for the Study of Liver Diseases.

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid